DDS-3D: Development of a medical, additively manufactured jaw implant of two combined polymers with optimized Young's modulus and time-controllable drug release over a period of at least 12 months

Project term: 2021 - 2024

Project leader IBMT: PhD Michael Teske

The aim of the project is to develop an additively manufactured jaw implant with substance depots that constantly release a healing-promoting substance. For this purpose, load-bearing polymer structures are developed for the manufacture of the implant and the release of the active ingredient.

The integrated drug depots are manufactured using hybrid 3D printing processes. The aim is to create patient-specific prostheses with bone-like properties to increase wearing comfort and reduce pressure points caused by the implant. The local drug depots serve to lower the drug dose to reduce side effects and to accelerate the osseointegration of the implant in the bone.



ASY-Dent: Development of a modular application system for individualized multicomponent active ingredient formulations in dental applications

Project term: 2023 - 2024

Project leader IBMT: Dr. rer. nat. Stefan Oschatz

Aim of this project is the development of patient-specific therapies for periodontal and endodontic disease patterns in dentistry, which can also have a decisive positive influence on the progression of major common medical conditions, e.g. diseases of the cardiovascular system or diabetes.

For this, the development of a modular application system for the combined use of paste-like active ingredient formulations is envisioned. The intended application system is versatile and can be used in different areas of the dentition and the periodontium, resulting in a high economic potential of the medical application in addition to the medical significance.